Biomedical Innovation

Search documents
Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines
Prnewswire· 2025-09-26 12:30
Core Insights - Alexandria Real Estate Equities, Inc. has announced the opening of Lilly Gateway Labs in San Diego, enhancing its collaborative Megacampus ecosystem aimed at biotechnology innovation [1][2][3] Company Overview - Alexandria Real Estate Equities, Inc. is a leading life science real estate investment trust (REIT) with a market capitalization of $25.7 billion and an asset base that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties under construction [5][6] Strategic Collaboration - The Lilly Gateway Labs operates in collaboration with Eli Lilly and Company, integrating Alexandria's real estate infrastructure with Lilly's scientific expertise and venture network [2][3] - This partnership aims to accelerate the development of early-stage biotech companies and foster collaboration between innovative biotechs and large pharmaceutical firms [3] Facility Features - The new Lilly Gateway Labs is located in a LEED Gold certified all-electric laboratory facility, featuring modular lab spaces, advanced scientific tools, and operational support services [4] - The facility is designed to support a diverse range of biotech companies focusing on various disease areas, including Alzheimer's, Parkinson's, cardiovascular diseases, and oncology [4] Ecosystem Development - Alexandria has been instrumental in developing the San Diego life science ecosystem since 1994, positioning the One Alexandria Square Megacampus as a hub for innovation and collaboration [3] - The Megacampus includes amenities such as a café, restaurant, event lawn, and proximity to renowned research institutions, enhancing the ability of tenants to attract and retain talent [3]
姚高员主持召开全市生物医药产业生态圈高质量发展工作座谈会
Hang Zhou Ri Bao· 2025-05-16 03:14
姚高员强调,要围绕大平台、大产业,按照"一核引领、四园协同、全域成链"的产业发展空间格 局,提升产业集聚度、加速布局前沿赛道、培育标志性产品和领军企业,打造生物医药产业新增长极。 要围绕大攻关、大转化,加强源头创新能力、做优企业创新平台、加快创新成果转化、夯实高水平人才 支撑,加快开创性基础研究和应用性基础研究,以科技创新推动产业创新。要围绕大招引、大投资,紧 盯生物医药龙头企业招引和内生裂变项目培育,推动更多项目"落地生根""开花结果"。杭州将持续优化 营商环境,常态化倾听企业需求建议,谋划推进一批有针对性的"牵一发动全身"政策举措,全力构建良 好产业生态,全链条支持企业创新发展,以更加精准高效的服务助力企业深耕杭州、成长壮大。 姚高员指出,做大做强生物医药产业是因地制宜发展新质生产力的重要突破口之一。要紧紧围绕加 快打造生物医药创新高地和产业高地的目标任务,切实增强信心底气、坚持目标导向、聚焦重点问题, 清醒分析差距,努力做大做强做优生物医药产业集群,不断塑造发展新动能新优势。 5月15日,市长姚高员主持召开全市生物医药产业生态圈高质量发展工作座谈会。他强调,要认真 学习贯彻习近平总书记关于科技创新、产业 ...